Introduction {#S1}
============

Cognitive impairment associated with hearing loss (HL) has recently attracted considerable interest due to growing evidence suggesting that impaired hearing is a risk factor for cognitive decline ([@B7]). Several studies have assessed the relationship between hearing deficits and cognitive impairment. Age-related hearing problems are common among people with dementia and are associated with poor cognitive function and reduced quality of life ([@B5]). Furthermore, hearing loss in later life has been associated with the risk of dementia. The impact of the risk factors for dementia may change during a person's lifespan, and whether or not midlife hearing loss represents a risk factor for dementia remains poorly understood ([@B30]). Osler et al. have shown that early identification and correction of hearing loss holds promise for the prevention of dementia later in life ([@B30]). Interventions aimed at improving sensory function may improve the quality of life of patients with dementia ([@B16]). Furthermore, middle-aged and old patients with severe or profound hearing impairments also show an increased risk of developing dementia ([@B13]). However, there are no reports on the effect of hearing loss in patients with cognitive impairment such as Alzheimer's disease (AD). If hearing loss facilitates cognitive decline in the normal population, then patients with AD and hearing loss may be expected to suffer more in the aspect of cognitive function. Therefore, we investigated the behavior, brain function, and changes in hearing in hearing loss-induced AD model mice using behavioral tests, positron emission tomography (PET), and magnetic resonance (MR) imaging.

Although many reports point to a correlation between dementia and hearing impairment, quantitative and functional studies are challenging because the auditory areas in the brain remain poorly understood and are difficult to assess. Deaf animal models provide us with an opportunity to assess the impact of hearing loss interventions on the development of dementia, as well as the corresponding changes in brain plasticity. We have previously demonstrated cross-modal and compensatory plasticity using PET analysis in an animal model ([@B32]). PET is a promising tool for the assessment of neuronal and cortical plasticity ([@B15]). The cochlear implant is a surgically implanted neuroprosthetic device that provides a sense of sound to a person with severe to profound sensorineural hearing loss ([@B2]; [@B9]). PET analyses of brain plasticity have provided quantitative results that support increased metabolic activity in auditory areas following cochlear implantation ([@B21]; [@B38]; [@B44]). Studies have also assessed verbal working memory in children with cochlear implants ([@B1]).

The aim of this study was to evaluate the effects of conductive hearing loss on Alzheimer's disease. We sought to investigate the following questions: (1) Does conductive hearing loss affect memory ability? (2) Does conductive hearing loss lead to functional changes in imaging studies such as PET and MR? Five familial AD mutation (5xFAD) transgenic mice (which are commonly used as an animal model for AD) were used in the current study ([@B37]; [@B29]; [@B10]; [@B24]). Experimental mice were divided into two groups: Alzheimer's disease with and without hearing loss (AD-HL and AD), and used PET and MR were used to evaluate changes in cerebral glucose metabolism and regional gray matter concentrations after the induction of conductive hearing loss. Memory deficits were assessed using the Y-maze and passive avoidance tests. To the best of our knowledge, our study is the first to investigate the relationship between AD and hearing loss through the evaluation of cerebral glucose metabolism and regional gray matter concentrations using PET and MR image analysis on animal models.

Materials and Methods {#S2}
=====================

Animals and Ethics Statement {#S2.SS1}
----------------------------

Five familial AD mutation male mice (2 months of age), which overexpress five familial AD mutations, were used in the current study. These mutations comprise three in human APP (695) with the Swedish (K670N, M671L), Florida (I716V), and London (V7171), and two in human presenilin1, PSEN1 M146L, and PSEN1 L286V. The transgenic mice were purchased from Jackson Laboratory (Bar Horbor, ME, United States). All applicable international, national, and/or institutional guidelines for the care and use of animals were followed. The animal study was approved by the Institutional Animal Care and Use Committee (IACUC) and the Institutional Review Board of the Korea Institute of Radiological and Medical Sciences (KIRAMS 2018-0016, KIRAMS 2015-38), and all experiments were performed in accordance with their guidelines.

Experimental Design {#S2.SS2}
-------------------

### Experimental Group {#S2.SS2.SSS1}

The animals were divided into two groups: the experimental group (AD-HL; *n* = 10) with induced conductive hearing loss and the control group (AD; *n* = 10) with normal hearing. Both groups underwent measurement of hearing thresholds, behavioral tests, and imaging studies.

### Hearing Loss {#S2.SS2.SSS2}

Conductive hearing loss was induced in the experimental group using the following procedure: The mice were anesthetized using intraperitoneal injections of ketamine (100 mg/kg) and xylazine (20 mg/kg). The tympanic membrane was resected using a sharp pick under continuous endoscopic visualization ([@B18]). After resection, the movement and balance state of the animals were checked to evaluate inner ear damage. The state of the tympanic membrane was endoscopically examined every week. Resection was repeated when the perforation size was observed to have decreased. The perforation size in the tympanic membrane was maintained until the end of the study ([Figure 1](#F1){ref-type="fig"}).

![Hearing loss was induced by resection of the tympanic membrane. **(A)** Normal tympanic membrane; **(B)** Resected tympanic membrane; **(C)** Experimental scheme for imaging and behavioral testing. Baseline tests were performed before induced hearing loss. Hearing loss was induced at 0 month, and PET, MR, and behavioral tests were performed 3 and 7 months after hearing loss.](fnins-14-00843-g001){#F1}

### Hearing Evaluation {#S2.SS2.SSS3}

Hearing levels were assessed using click-evoked ABRs 1 week after surgery, 3 months later, and at the end of the study. Hearing levels were tested by evaluating the auditory brainstem responses (ABRs) to click stimuli (Intelligent Hearing System, Miami, FL, United States). Subdermal needle electrodes were located below both ear and at the vertex. The stimulus rate is 19.3/s using click sound of rarefaction mode. The response was amplified, and band pass filtered (100--3000 Hz), and averaged over stimulation (512 sweeps per stimulation).

PET Statistical Parametric Mapping (SPM) and MR Voxel-Based Morphometry (VBM) Analyses {#S2.SS3}
--------------------------------------------------------------------------------------

PET and MR scans were acquired at baseline and at 3 and 7 months after the induction of hearing loss in order to assess changes in cerebral glucose metabolism and gray matter concentrations ([Figure 1C](#F1){ref-type="fig"}).

Regional cerebral glucose metabolism was measured using the F-18 fluorodeoxyglucose (F-18 FDG) PET scan (Siemens Inveon PET scanner) ([@B3]). Prior to the PET scan, the mice (*n* = 10 per group, male) underwent an 8-h fasting period, after which they were anesthetized with 2% isoflurane in 100% oxygen (Forane solution; Choongwae Pharma, South Korea). The body temperatures of the mice were maintained at 36°C using heating pads during the course of the scan. Next, 200 μCi of F-18 FDG was injected through the tail vein of the mice. After 30 min of uptake, emission PET data were acquired for 30 min using an energy window of 350--650 keV. The emission list-mode data were sorted into three-dimensional (3D) sinograms and reconstructed using 3D reprojection algorithms without the use of a filter. The size of the image matrix was 256 × 256 × 159, with a pixel size of 0.155 mm × 0.155 mm and a slice thickness of 0.796 mm.

Regional differences between groups were identified using voxel-based statistical analysis performed in SPM 8^[1](#footnote1){ref-type="fn"}^. Statistical parametric mapping analysis on small animals has been described in our previous study ([@B12]). Briefly, the brain tissue was extracted from the image and a study-specific mouse brain template was constructed using structural images. Individual PET data were spatially normalized onto the mouse brain template using affine and non-linear transformations. The voxel size of the spatially normalized images was 0.3 mm × 0.3 mm × 0.3 mm. Finally, a Gaussian smoothing kernel with a full-width at half-maximum (FWHM) value of 3 mm was applied to enhance the signal-to-noise ratio. Count normalization was performed. *t*-tests were used to identify regional differences in cerebral glucose metabolism between the groups (*p* \< 0.005 or *p* \< 0.05, uncorrected).

T2w 3D MR images were acquired using an Agilent 9.4 T MR scanner (United States). An AD quad 70 RF coil was used, and the matrix size was 192 × 192 × 192. The repetition time (RT) was 2500 ms. The effective echo time (TE) was set at 7 ms. The total image acquisition time was 3 h 36 min.

Modulated VBM analysis was performed in SPM eight to compare the regional gray matter concentrations in selected brain regions between the groups ([@B42]). Skull stripping was performed using the BrainSuite (version 16) software ([@B11]). Parameters including the brain surface extractor diffusion iterations, diffusion constant, edge constant, and erosion size were adjusted for skull stripping using individual T2w 3D MR data. A predefined gray matter template (matrix size: 512 × 512 × 512; voxel size: 0.04 mm × 0.04 mm × 0.04 mm) created by the Delora research team was used for spatial normalization ([@B11]; [@B6]). Individual skull-stripped MR data were spatially normalized onto the template and smoothed with a Gaussian smoothing kernel with a full-width at half-maximum (FWHM) value of 2 mm. Paired *t*-tests were used to identify regional differences in gray matter concentrations between the groups (*p* \< 0.005, uncorrected).

Behavioral Analysis {#S2.SS4}
-------------------

### Y-Maze Test {#S2.SS4.SSS1}

The Y-maze test was used to measure spatial working memory and reference memory, which were assessed by recording spontaneous alternation behavior ([@B14]). Activity was recorded for 8 min and analyzed by a computer program (Viewer3, BIOSERVE, St. Augustin, Germany). Alternation was defined as successive entries into three different arms on overlapping triplet sets. Percentage alternation was calculated as the ratio of actual alternation and possible alternation (defined as the total number of arm entries -- 2) × 100, as follows:
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### Passive Avoidance Test {#S2.SS4.SSS2}

The responses to aversive stimuli in the passive avoidance test were used to assess learning and long-term memory ([@B41]; [@B25]). The setup consisted of two rooms separated by a steel board such that it could automatically be moved up and down to allow movement of the animal from one room to the other. Both the rooms were equipped with a scrambler on the floor, through which electrical stimulation could be delivered to the foot. During the adaptation session (Day 1), the mice were allowed to travel freely between the two rooms for 5 min. On Day 2, the steel board was used to separate the rooms and the mouse was placed in one of the rooms. The room was kept dark for 60 s to allow the mouse to adjust to the darkness, after which the light was turned on and the steel panel was simultaneously removed. As the mouse traveled across to the other room to avoid the bright light, the movement of the mouse triggered the steel panel to shut, and an electrical shock impulse (0.3 mA, 2 s) was transmitted to the grill. After 24 h (Day 3), the mice were subjected to the same trial without the electrical shock stimulus. The time taken by the mice to cross over to the other room was automatically recorded.

Statistics {#S2.SS5}
----------

Data are presented as mean ± standard error of mean (SEM). For behavioral tests, the differences among the groups were analyzed using the one-way ANOVA test and the difference between two groups were analyzed with Student's unpaired *t*-test in GraphPad Prism five (GraphPad software, CA, United States). A *P*-value less than 0.05 was considered statistically significant.

Results {#S3}
=======

Measurement of the Level of Hearing Loss {#S3.SS1}
----------------------------------------

The mean hearing level measured using click-evoked ABRs was 20 dB sound pressure level (SPL) at the normal hearing state ([Figure 2A](#F2){ref-type="fig"}). In the control group, the hearing level was increased to 40 dB SPL at 3- and 7-months. In the experimental group, the mean hearing level was 65 dB SPL in both ears after resection of the tympanic membrane ([Figure 2B](#F2){ref-type="fig"}). The final mean hearing levels at 7 months after the induction of hearing loss were 62.9 ± 8 dB SPL on the right side and 67.1 ± 7 dB SPL on the left side ([Figure 2C](#F2){ref-type="fig"}).

![Auditory brainstem responses results in the AD-HL and AD groups. **(A)** Auditory brainstem responses in the AD group revealed a hearing threshold of 20 dB SPL at the initial state. **(B)** Auditory brainstem responses in the AD-HL group revealed a hearing threshold of 65 dB SPL at 3 months. **(C)** Mean (±SEM) ABR threshold (dB SPL) for 3 and 7 months after hearing loss. \[ABR: auditory brainstem response, \*significant difference between control and hearing loss group at 3 and 7 mo (*P* \< 0.05)\]. AD-HL, Alzheimer's disease with hearing loss; AD, Alzheimer's disease; dB SPL, decibel sound pressure level; SEM, standard error of the means.](fnins-14-00843-g002){#F2}

Evidence From PET and MR Imaging {#S3.SS2}
--------------------------------

### Cerebral Glucose Metabolism in the AD Group {#S3.SS2.SSS1}

SPM analysis of PET scans obtained at baseline and at the 3-month time-point in the AD group revealed decreased cerebral glucose metabolism in the frontal association cortex (FrA; *P* \< 0.005; [Figure 3A](#F3){ref-type="fig"}) and the cerebellum (Cb; *P* \< 0.05; [Figure 3B](#F3){ref-type="fig"}) at 3 months compared to baseline levels.

![SPM analysis of PET images; **(A,B)** Control vs AD; **(C,D)** AD vs AD-HL (3 mo); **(E)** AD vs AD-HL (7 mo); We found a decrease in the cerebral glucose metabolism in the **(A)** FrA (*p* \< 0.005); and **(B)** Cb (*p* \< 0.05) at the 3-month timepoint compared to the baseline levels. We found lower cerebral glucose metabolism in the **(C)** FrA (*P* \< 0.005), and **(D)** CA2 region of the hippocampus and Cb (*P* \< 0.05) in the AD-HL group than in the AD group at the 3-month timepoint after the induction of hearing loss. **(E)** The cerebral glucose metabolism in the FrA was lower in the AD-HL group than in the AD group (*p* \< 0.005) at the 7-month time point after the induction of hearing loss. *P-*values were determined using the paired *t*-test. SPM, statistical parametric mapping; AD-HL, Alzheimer's disease with hearing loss; AD, Alzheimer's disease; FrA, frontal association cortex; Cb, cerebellum.](fnins-14-00843-g003){#F3}

### Comparison Between Cerebral Glucose Metabolism of the AD and AD-HL Groups {#S3.SS2.SSS2}

[Figure 5](#F5){ref-type="fig"} illustrates the results of the SPM analysis comparing PET scans of animals in the AD and AD-HL groups at 3 and 7 months after the induction of hearing loss. Cerebral glucose metabolism in the FrA was lower (*P* \< 0.005) in the AD-HL group than in the AD model 3 and 7 months after the induction of hearing loss (shown in [Figures 3C,E](#F3){ref-type="fig"}). We also found lower cerebral glucose metabolism in the hippocampus (CA1) and Cb 3 months after the induction of hearing loss ([Figure 3D](#F3){ref-type="fig"}; *P* \< 0.05).

### Cerebral Gray Matter Concentrations in the AD and AD-HL Mice {#S3.SS2.SSS3}

[Figure 4](#F4){ref-type="fig"} illustrates the results of the optimized VBM analysis comparing the MR images of mice in the AD and AD-HL groups. We found no differences in the gray matter concentrations of the two groups at the 3-month time-point after the induction of hearing loss (*P* \< 0.005). However, at the 7-month time-point after the induction of hearing loss, the AD-HL group showed lower gray matter concentrations in large areas of the brain including the FrA, simple lobule (Sim, part of the cerebellum), RSA (retrosplenial agranular cortex), cingulate/retrosplenial cortex (Cg/RS), substantia nigra (SNR), retroethmoid nucleus (REth), medial geniculate nucleus (MGV), and anterior pretectal nucleus (APTD) than the AD group (*P* \< 0.005).

![Comparison of VBM results between the AD-HL and AD groups. **(A)** We found no group differences in gray matter concentrations at the 3-month time point after the induction of hearing loss (*P* \< 0.005). **(B)** We found a significant decrease in the gray matter concentrations in several regions including the FrA, Sim, RSA, Cg/RS, SNR, REth, MGV, and APTD (*P* \< 0.005) at the 7-month time point after the induction of hearing loss. *P-*values were determined using *t*-test. VBM, voxel-based morphometry; AD-HL, Alzheimer's disease with hearing loss; AD, Alzheimer's disease; FrA, frontal association cortex; Sim, simple lobule (part of the cerebellum); RSA, retrosplenial agranular cortex; Cg/RS,: cingulate/retrosplenial cortex; SNR, substantia nigra; REth, retroethmoid nucleus; MGV, medial geniculate nucleus; APTD, anterior pretectal nucleus.](fnins-14-00843-g004){#F4}

Behavioral Analysis {#S3.SS3}
-------------------

The AD-HL and AD groups underwent behavioral assessment prior to the induction of conductive hearing loss (baseline) when they were 6 weeks old, and at the 3- and 7-month time-points after induction of hearing loss (in the AD-HL group). None of the animals showed balance or movement problems after resection of tympanic membrane. We assessed the effect of hearing loss on spatial memory using the Y-maze test. The AD group showed an age-dependent decline in working memory. We found no significant difference between the AD and AD-HL groups in the spontaneous alternation as evaluated by the Y-maze ([Figure 5A](#F5){ref-type="fig"}) at the 3- and 7-month time-points after hearing loss. However, the AD group tended to show higher spatial memory compared to the AD-HL group.

![Comparison of behavioral changes between the AD-HL and AD groups. **(A)** In the Y-maze, we found no significant group differences in the percentage of spontaneous alternation at any of the tested time-points. However, the AD group tended to exhibit higher spatial memory than the AD-HL group at the 3- and 7-month time-points. **(B)** In the passive avoidance memory test, compared to the AD group, the AD-HL group exhibited significantly higher latency time at the 3- and 7-month time-points, indicating higher memory impairment. Data are represented as mean ± SEM. \**P* \< 0.05, \*\**P* \< 0.01 (vs AD group). *P*-values were calculated using *t*-test. AD-HL, Alzheimer's disease with hearing loss; AD, Alzheimer's disease; SEM, standard error of the means; SAP, spontaneous alternation percentage.](fnins-14-00843-g005){#F5}

The passive avoidance test was performed to examine the hearing loss-induced memory impairment in the AD-HL group. We found no significant difference in cognitive performance in the passive avoidance test between the two groups prior to the induction of hearing loss. The AD-HL group exhibited significantly higher memory impairment 24 h after the training sessions with the electric shock stimulus than the AD group at the 3-month (mean latency: 210 s in AD vs 87 s in AD-HL, *p* = 0.0037) and 7-month (mean latency: 157 s in AD vs 95 s in AD-HL, *p* = 0.046) time-points following hearing loss induction ([Figure 5B](#F5){ref-type="fig"}).

Discussion {#S4}
==========

Several meta-analyses, including a meta-analysis of a prospective cohort study, have suggested that hearing impairment significantly increases the risk of developing cognitive disorders ([@B46]). The importance of evaluating hearing levels and administering appropriate rehabilitation treatments as part of the cognitive assessment and management plan in individuals with cognitive disorders has also been emphasized ([@B26]). Further, age-related hearing loss has been considered to be a possible biomarker and modifiable risk factor for cognitive decline, cognitive impairment, and dementia ([@B20]).

Although meta-analyses and cohort studies have indicated a relationship between hearing loss (hearing impairment or deafness) and cognitive impairment, PET or MR image analyses or behavioral studies have not been employed to further characterize the relationship until now. Imaging studies using PET have provided a translational platform for clinical use and successful clinical proof-of-concept testing ([@B34]; [@B8]). FDG-PET imaging has been used to visualize the distribution of neural damage or synaptic dysfunction; to identify distinct phenotypes of neurodegenerative disorders such as AD ([@B22]), and to identify changes in cerebral glucose metabolism after the onset of deafness, or in brain plasticity after cochlear implantation ([@B28]; [@B38]; [@B39]; [@B44]). In the present study, we constructed an AD-HL animal model. This 5xFAD mouse showed peripheral hearing loss with aging ([@B29]). At 4-months-old, the hearing level was normal, but at 14-months-old, the hearing level was much lower than that of the wild type mouse; this has been shown to be an aggravating factor for cognitive decline. Another study was used an animal model of amyloid-β infusion to intracerebroventricular space in order to generate a suitable model for AD; in this study, deafness was induced using cochlear ablation Cognitive behavioral tests were subsequently performed, and amyloid-β infused group showed poor performance and greater loss of synapses in the hippocampus ([@B4]).

In the current study, we assessed cerebral glucose metabolism, regional gray matter concentrations changes using PET, MR imaging, and behavioral tests. We found reduced glucose metabolism in the FrA (*P* \< 0.005), hippocampus, and Cb (*P* \< 0.05) in the AD-HL group 3 months after the induction of hearing loss. Interestingly, this functional change was not accompanied by changes in regional gray matter concentrations at the corresponding sites. Memory decline was confirmed using the passive avoidance test. Lower cerebral glucose metabolism levels in the FrA and hippocampus related to memory deficits have also been found in our previous PET study ([@B31]; [@B19]; [@B43]). Furthermore, other groups have reported cognitive decline-associated decreases in cerebral glucose metabolism in the Cb ([@B36]; [@B17]; [@B27]). In the current study, the decrease in the cerebral glucose metabolism in the FrA persisted at the 7-month time-point. Furthermore, VBM analysis also revealed decreases in gray matter concentrations in the Sim, RSA, and Cg/RS in the AD-HL group. The Cg/RS and RSA are known to be the key brain areas involved in memory, emotion, and attention functions ([@B45]; [@B23]).

However, we noted a discrepancy in the results from PET and MR image analyses. Although we found group differences in the regional gray matter concentrations in several areas of the brain at the 7-month time point, SPM analysis of PET imaging data did not reveal differences in glucose metabolism at the corresponding sites, except in the case of the FrA. This discrepancy could be explained by brain plasticity. Although the glucose metabolism decreased in the hippocampus and Cb 3 months after the induction of hearing loss, the metabolism in these regions recovered by 7 months, possibly due to brain plasticity. This type of recovery has been previously reported both in humans and cats ([@B15]; [@B32]). In previous studies, the primary auditory cortex showed hypometabolism after deafness, and then, the hypometabolic area was normalized further after even the ear was still deaf. They explained this phenomenon as an evidence of cross-modal plasticity. Therefore, in our study, CA2 area showed hypometabolism at 3 months after hearing loss; however, the change was normalized at 7 months after hearing loss, even the hearing loss and behavioral deficit were still remained. In addition, the results of the VBM analysis suggest differences in gray matter concentration in several areas of the brain, including the FrA.

Our findings suggest that the decrease in cerebral glucose metabolism in the hippocampus is correlated with memory deficits, such as those affecting long-term memory ([@B35]). The results of the passive avoidance test support the development of memory deficits induced by hearing loss, especially in terms of long-term memory. Additionally, we found no changes in regional gray matter concentrations in the whole brain at the 3-month time-point, which implies that there were changes only in the glucose metabolism at this time. However, we found significant changes in the gray matter concentrations in memory and motor function-related brain areas at 7 months after the induction of hearing loss. SPM analysis of PET images at 7 months revealed a recovery in the impaired glucose metabolism in the Cb at this time point.

Interestingly, we did not find significant changes in glucose metabolism or gray matter concentration in the auditory cortex at the 3- or 7-month time-points after the onset of hearing loss. We believe this may be because our mouse model with hearing loss did not constitute complete deafness. In our conductive hearing loss model, the mice could still hear loud sounds. As the auditory system was still functional, loud sounds could evoke activation of the auditory system. However, we found lower cerebral glucose metabolism in the FrA in the AD-HL group than in the AD group. The FrA is composed of the prefrontal cortex and motor function-related areas of the brain excluding the primary motor cortex ([@B40]). Neurophysiology and neuropsychology studies have established that the dorsolateral prefrontal cortex is associated with working memory, while the ventral frontal lobe is associated with auditory and audiovisual working memory ([@B33]). Our PET findings revealed decreased glucose metabolism in the dorsolateral prefrontal cortex at the 3-month time-point after induction of hearing loss in the AD-HL mice. However, by the 7-month time-point, the glucose metabolism in the ventral prefrontal cortex, as well as in the dorsolateral prefrontal cortex regions was affected. This finding suggests that auditory areas including the ventral prefrontal cortex were affected despite the fact that we did not induce complete hearing loss.

Conclusion {#S5}
==========

Our findings reveal memory impairment after hearing loss in the AD mice as evidenced by PET and MR imaging findings. The results from our behavioral tests also support an association between memory impairment and hearing loss. Together, these results suggest that hearing loss may aggravate memory decline in an animal model of AD.

In sum, we constructed an AD-HL animal model and assessed changes in cerebral glucose metabolism and gray matter concentrations following hearing loss. Our results provide experimental evidence to suggest that even partial hearing loss can aggravate memory impairment in AD. In the future, this model can also be used to identify the onset of memory deficit and brain plasticity following the onset of hearing loss.
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